share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H

SEC announcement ·  Mar 19 16:23
Summary by Moomoo AI
On March 18, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase of the company's common stock. The transaction involved the acquisition of 13 shares at a price of $762.66 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,614 shares. The transaction, which was conducted in USD, is classified as a 'Grant, award or other acquisition' according to the transaction code description. This financial activity reflects a continued investment in the company by Johnson and may be of interest to current and potential investors.
On March 18, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase of the company's common stock. The transaction involved the acquisition of 13 shares at a price of $762.66 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,614 shares. The transaction, which was conducted in USD, is classified as a 'Grant, award or other acquisition' according to the transaction code description. This financial activity reflects a continued investment in the company by Johnson and may be of interest to current and potential investors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more